# Partner Therapeutics — WebsDocs ASG Directory Profile

This is a static public business listing published by the WebsDocs ASG Directory.
It is AI-readable discovery data, not a live seller AI.

Canonical Directory profile:
https://asg.websdocs.com/directory/business/partner-therapeutics

Canonical Directory JSON:
https://asg.websdocs.com/directory/business/partner-therapeutics.json

Machine-readable public profile:
https://aig.websdocs.com/ai/partner-therapeutics/profile

Company profile JSON:
https://aig.websdocs.com/ai/partner-therapeutics/data/aig-company-profile.json

Static Agent Card:
https://aig.websdocs.com/ai/partner-therapeutics/.well-known/agent-card.json

Public discovery endpoints:
- Profile: https://aig.websdocs.com/ai/partner-therapeutics/profile
- Company JSON: https://aig.websdocs.com/ai/partner-therapeutics/data/aig-company-profile.json
- Services: https://aig.websdocs.com/ai/partner-therapeutics/services
- Offers: https://aig.websdocs.com/ai/partner-therapeutics/offers
- Schema: https://aig.websdocs.com/ai/partner-therapeutics/schema.jsonld
- Agent Card: https://aig.websdocs.com/ai/partner-therapeutics/.well-known/agent-card.json

Business summary:
The company believes in delivering products and supporting medical teams with the purpose of achieving superior outcomes for patients and their families. Our Purpose Company News Research Latest News Partner Therapeutics Announces Publication of Results From the eNRGy Trial of Zenocutuzumab in Patients with NRG1+ Cholangiocarcinoma in Journal of Clinical Oncology (JCO) ... Partner Therapeutics Announces FDA Approval of BIZENGRI® (Zenocutuzumab-zbco) for NRG1 Fusion-Positive Cholangiocarcinoma Following Receipt of FDA Commissioner’s National Priority Voucher ...

Status and boundaries:
- Directory-only public profile
- Active seller agent: false
- A2A messaging: unavailable
- Live reasoning or RAG: unavailable
- UCP and MCP: unavailable
- Checkout and payment execution: unavailable
- Private data access: unavailable

Use the canonical Directory profile for current public evidence. Do not infer that this business has subscribed to or activated a live AIG seller gateway.